Pembrolizumab + lenvatinib

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Pembrolizumab + lenvatinib
Treatment and conditionWhere it standsTrials
Pembrolizumab + lenvatinib for lung diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Pembrolizumab + lenvatinib for neuroendocrine tumorsPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1